Replies to post #774904 on NorthWest Biotherapeutics Inc (NWBO)

[attilathehunt]

When do you expect to hear of a decision from MHRA on NWBO's application fro DCVax-L?

[Bright Boy]

Thanks my friend!! NWBO's got this and is lightyears ahead in this game!!!

Cheers,

BB

[beartrap12]

Slave1, Love your posts! Question: Could the Mill Creek research/libray be one of the in-licencing projects that management talks about in its Quarterlies/Annual reports?
And thank you for the detail in the below paragraph. Also, is Mill Creek a business, hospital, clinic??

Slave wrote:

On Mill Creek, their approach may look different on the surface, using in vitro-expanded tumor cell lines to generate an antigen library, but the downstream process still appears to involve dendritic cells, patient matching, and antigen presentation. So yes, there’s definitely conceptual overlap.

That said, this isn’t unusual. Trials like these, especially in academic settings, are often built on in-licensed platforms or shared technology foundations. In fact, many are intentionally structured to evaluate specific components of an existing system under new conditions or to generate complementary data. So this is not a threat to NWBO’s IP, it’s likely a strategic parallel effort, not a competing one.